Skip to main content
. Author manuscript; available in PMC: 2019 Jul 25.
Published in final edited form as: Expert Opin Pharmacother. 2014 Feb 11;15(5):711–716. doi: 10.1517/14656566.2014.889116

Table 1.

Adverse events associated with ABT-450 [29].

Adverse event Frequency
Fatigue 35 – 47%
Nausea 21 – 24%
Headache 14 – 26%
Dizziness 5 – 29%
Insomnia Up to 26%
Skin rash 6 – 21%
Vomiting Up to 21%
Pruritus Up to 21%
Anemia 6.5%